Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: The Insulin Resistance Atherosclerosis Study

Diabetes

Volumn 45, Issue 6, 1996, Pages 742-748

  Haffner, Steven M ^a   D'Agostino Jr , Ralph ^b   Saad, Mohammed F ^c   Rewers, Marian ^d   Mykkänen, Leena ^a,e   Selby, Joseph ^f   Howard, George ^b   Savage, Peter J ^g   Hamman, Richard F ^d   Wagenknecht, Lynne E ^b   Bergman, Richard N ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f DIVISION OF RESEARCH   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY FAT; CAUCASIAN; DIET RESTRICTION; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; ARTERIOSCLEROSIS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HISPANIC AMERICANS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MEXICO; MIDDLE AGED; UNITED STATES;

EID: 0030013917     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.6.742     Document Type: Review

References (50)

1. DeFronzo RA: Lilly Lecture 1987: the Triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
2. Reaven GM, Bernstein R, Davis B: Non-ketotic diabetes mellitus: insulin deficiency or insulin resistance. Am J Med 60:80-88, 1976
3. Porte D: Banting Lecture 1990: β cells in type II diabetes mellitus. Diabetes 40:166-180, 1991
4. Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505, 1978
5. Gardner LI, Stern MP, Haffner SM, Gaskill SP, Hazuda HP, Relethford JH, Eifler CW: Prevalence of diabetes in Mexican Americans: relationship to percent gene pool derived from Native American sources. Diabetes 33:86-92, 1984
6. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
7. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC: Methods and prevalence of non-insulin dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311, 1989
8. Harris MI: Non-insulin dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev 6:71-90, 1990
9. Cowie CC, Harris MI, Silverman RE, Johnson EW, Rust KF: Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol 137:719-732, 1993
10. Nagulesparan M, Savage PJ, Knowler WC, Johnson GC, Bennett PH: Increased in vivo insulin resistance in non-diabetic Pima Indians compared with Caucasians. Diabetes 31:952-956, 1982
11. Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, Bogardus C: Exaggerated early insulin release and insulin resistance in a diabetes prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866-876, 1991
12. Haffner SM, Bowsher RR, Mykkänen L, Hazuda HP, Mitchell BD, Valdez RA, Gingerich R, Monterossa A, Stern MP: Proinsulin and specific insulin concentration in high and low risk populations for non-insulin dependent diabetes mellitus. Diabetes 43:1490-1493, 1994
13. Boyko EJ, Keane EM, Marshall JA, Hamman RF: Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. Diabetes 40:509-515, 1991
14. Haffner SM, Stern MP, Dunn JF, Mobley M, Blackwell J, Bergman RN: Diminished insulin sensitivity and increased insulin response in non-obese, non-diabetic Mexican Americans. Metabolism 39:842-847, 1990
15. Haffner SM, Stern MP, Watanabe R, Bergman RN: Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. Eur J Clin Invest 22:147-153, 1992
16. Rubenstein AH, Seftel HC, Miller K, Bersohn I, Wright AD: Metabolic response to oral glucose in healthy South African white, Indian, and African subjects. Br Med J 1:748-751, 1969
17. Cruickshank JK, Cooper J, Burnett M, MacDuff J, Drubra U: Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 338:842-847, 1991
18. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382-386, 1981
19. Svec F, Nastasi K, Hilton C, Bao W, Srinivasan SR, Berenson GS: Black-white contrasts in insulin levels during pubertal development: the Bogalusa Heart Study. Diabetes 41:313-317, 1992
20. Osei K, Cottrell DA, Harris B: Differences in basal and poststimulation glucose homeostasis in non-diabetic first degree relatives of black and white patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 75:82-86, 1992
21. Manolio TA, Savage PJ, Burke GL, Hilner JE, Liu K, Orchard TJ, Sidney S, Oberman A: Correlates of fasting insulin levels in young adults: the Cardia Study. J Clin Epidemiol 44:571-578, 1991
22. Banerji MA, Lebovitz HE: Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 38:784-792, 1989
23. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocrine Rev 6:45-86, 1985
24. Wagenkneckt LE, Mayer EJ, Rewers M, Haffner SM, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design and recruitment results. Ann Epidemiol 5:464-471, 1995
25. World Health Organization: Diabetes Mellitus Report of a WHO Study Group. Geneva, World Heath Organization, 1985 (Tech. Rep. Ser., no. 727)
26. Herbert V, Lau K, Gottlieb C, Bleicher S: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
27. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsitivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
28. Welch S, Gebhart SSP, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
29. Steil GM, Volund A, Kahn SE, Bergman RN: Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: suitability for use in population studies. Diabetes 42:250-256, 1993
30. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, Sands RE, Pei D, Savage PJ, Bergman RN: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
31. Dowling HJ, Pi-Sunyer FX: Race-dependent health risks of upper body obesity. Diabetes 42:537-543, 1993
32. Conway JM, Yanovski SZ, Avila NA, Hubbard VS: Visceral tissue differences in black and white women. AJCN 61:765-771, 1994
33. Banerji MA, Chaiken RL, Gordon D, Kral JG, Lebovitz HE: Does intraabdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin sensitive. Diabetes 44:141-146, 1995
34. Karter A, Mayer E, Monaco J, Hamman R, Scholinsky P, Selby J for the IRAS Investigators: Insulin sensitivity and waist/hip ratio (WHR) in normoglycemic non-Hispanic whites, African Americans and Hispanics: the Insulin Resistance Atherosclerosis Study (IRAS) (Abstract). Diabetes 44(Suppl. 1):15A, 1995
35. Fontbonne A, Papoz L, Eschwege E, Roger M, Saint-Paul M, Simon D: Features of insulin resistance syndrome in men from French Caribbean Islands: the Telecom Study. Diabetes 41:1385-1389, 1992
36. Osei K, Schuster DP: Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in black and white Americans. Diabetic Med 11:755-762, 1994
37. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D: Disproportionate elevation of immunoreactive proinsulin in type II (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702, 1987
38. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type II (non-insulin dependent) diabetes mellitus. Diabetologia 31:355-360, 1988
39. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN: Insulin deficiency and increased plasma concentrations of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 10:313-320, 1993
40. Kosaka K, Hagura R, Kuzuya T: Insulin responses in equivocal and definite diabetes with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 26:944-952, 1977
41. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Waldenström J: Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes. Diabetic Med 7:407-413, 1990
42. Philips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and secretion. Diabetic Med 11:286-292, 1993
43. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of non-insulin dependent diabetes mellitus in Mexican Americans. Diabetes 44:1386-1391, 1995
44. Sicree RA, Zimmett PZ, King HOM, Coventry JS: Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years. Diabetes 36:179-186, 1987
45. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1506, 1988
46. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E: Risk factors for NIDDM in white population: Paris Prospective Study. Diabetes 40:796-799, 1991
47. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
48. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:903-915, 1990
49. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body fat distribution. Diabetes 39:283-288, 1990
50. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased ultra-abdominal fat distribution with development of NIDDM in Japanese American men. Diabetes 39:104-111, 1990